Moreover, gene expression meta-analysis29 using 4411 patients from 30 studies further demonstrated that CEBPB expression was a risk factor for the survival of patients with ovarian cancer (Fig. 2c and Supplementary Figure 6b). This evidence concerns the gene CEBPB and ovarian carcinoma.